Clinical Trial Detail

NCT ID NCT04337580
Title Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer (FASN)
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications

prostate cancer

Therapies

Cabazitaxel + Omeprazole

Docetaxel + Omeprazole

Age Groups: adult senior

No variant requirements are available.